To combat with multifaceted cachectin (experience with infliximab used for unregistered indications
Saved in:
| Main Authors: | Dmitry Evgenyevich Karateyev, T G Sinelnikova, P F Litvitsky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2011-06-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/714 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USE OF RITUXIMAB IN AUTOIMMUNE DISEASES: NEW ASPECTS
by: Dmitry Evgenyevich Karateyev
Published: (2010-09-01) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01) -
A CURRENT VIEW ON THE PROBLEM OF RAPIDLY PROGRESSIVE RHEUMATOID ARTHRITIS
by: Dmitry Evgenyevich Karateyev
Published: (2010-06-01) -
REGISTERED vs. UNREGISTERED TRADE MARKS IN THE EUROPEAN UNION
by: George-Mihai IRIMESCU
Published: (2018-05-01) -
Target-aware unregistered infrared and visible image fusion
by: Dengshu Hu, et al.
Published: (2025-06-01)